Table 1.
Strain | Number of rats | Initial MAP | Delta MAP fasudil | MAP after fasudil | Delta MAP additive nifedipine |
MAP after fasudil + nifedipine |
---|---|---|---|---|---|---|
SHR | 10 | 180 ± 3∗ | −56 ± 3∗ | 124 ± 2∗ | −45 ± 2∗ | 79 ± 2∗ |
WKY | 8 | 110 ± 3 | −35 ± 3 | 75 ± 2 | −17 ± 2 | 58 ± 2 |
| ||||||
TGR | 12 | 164 ± 4∗ | −64 ± 7∗ | 101 ± 4 | −35 ± 3∗ | 66 ± 3 |
HanSD | 11 | 124 ± 3 | −29 ± 5 | 95 ± 3 | −25 ± 2 | 69 ± 2 |
| ||||||
SS/Jr-HS | 6 | 182 ± 9∗# | −75 ± 8∗# | 108 ± 2∗ | −38 ± 3 | 69 ± 4 |
SS/Jr-LS | 6 | 140 ± 7∗ | −38 ± 3∗ | 101 ± 4 | −37 ± 5 | 64 ± 3 |
SR/Jr-HS | 8 | 118 ± 4 | −21 ± 2 | 97 ± 2 | −31 ± 2 | 66 ± 2 |
SR/Jr-LS | 8 | 122 ± 3 | −23 ± 4 | 99 ± 2 | −32 ± 2 | 68 ± 1 |
Data are means ± SEM. Significantly different (p < 0.05) ∗from the respective normotensive controls and #from the corresponding rat strain fed a low-salt diet.